As of 2024-12-15, the Relative Valuation of Kaleido Biosciences Inc (KLDO) is (14,705,069.79) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.29 USD, the upside of Kaleido Biosciences Inc based on Relative Valuation is -5070713820.9%.
The range of the Relative Valuation is (13,627,306.91) - (15,246,995.76) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
Range | Selected | |
Trailing P/E multiples | 20.4x - 25.0x | 23.2x |
Forward P/E multiples | 22.4x - 26.2x | 25.2x |
Fair Price | (13,627,306.91) - (15,246,995.76) | (14,705,069.79) |
Upside | -4699071448.8% - -5257584844.2% | -5070713820.9% |
Date | P/E |
2024-11-29 | 0.00 |
2024-11-27 | 0.00 |
2024-11-26 | 0.00 |
2024-11-25 | 0.00 |
2024-11-22 | 0.00 |
2024-11-21 | 0.00 |
2024-11-20 | 0.00 |
2024-11-19 | 0.00 |
2024-11-13 | 0.00 |
2024-11-12 | 0.00 |
2024-11-07 | 0.00 |
2024-11-06 | 0.00 |
2024-11-05 | 0.00 |
2024-10-31 | 0.00 |
2024-10-28 | 0.00 |
2024-10-24 | 0.00 |
2024-10-23 | 0.00 |
2024-10-22 | 0.00 |
2024-10-21 | 0.00 |
2024-10-18 | 0.00 |
2024-10-16 | 0.00 |
2024-10-15 | 0.00 |
2024-10-10 | -0.00 |
2024-10-04 | 0.00 |
2024-10-03 | 0.00 |
2024-10-01 | 0.00 |
2024-09-24 | 0.00 |
2024-09-20 | 0.00 |
2024-09-16 | 0.00 |
2024-09-12 | 0.00 |